Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Peripheral Numbness and Tingling Guidelines

Initial Clinical Assessment

  • The American College of Physicians recommends determining fiber type involvement by asking specifically about burning pain and tingling (small fiber) versus numbness with loss of balance (large fiber) 1, 2
  • The American Academy of Neurology suggests assessing distribution pattern: distal symmetric suggests metabolic/toxic causes; patchy or asymmetric suggests mononeuropathy multiplex from vasculitis or leprosy 1
  • Identify red flags for urgent evaluation: hemibody sensory loss without motor weakness requires stroke evaluation within 48 hours 1
  • Medication review focusing on metformin (especially ≥2g daily), chemotherapy agents, and statins as common culprits 1

Physical Examination

  • The American Academy of Neurology recommends small fiber testing: pinprick sensation and temperature perception 2, 3
  • Large fiber testing: vibration perception with 128-Hz tuning fork, 10-g monofilament testing, and ankle reflexes 1, 3
  • Autonomic signs: check for orthostatic hypotension, resting tachycardia, and skin dryness/cracking 3

Initial Laboratory Workup

  • Order complete blood count (anemia, infection, malignancy screening) 3
  • Fasting blood glucose and HbA1c (diabetes is the most common treatable cause) 1, 3
  • Vitamin B12 level (especially critical if patient takes metformin) 1
  • Hepatitis C serology if risk factors present (up to 50% of HCV patients develop neuropathy) 1

Treatment Approach

  • Optimize glycemic control if diabetic (HbA1c target 6-7%); this is the only proven strategy to prevent or delay diabetic neuropathy progression 1, 3
  • Vitamin B12 supplementation at 2500 mcg daily if deficient, particularly in metformin users 1
  • First-line pharmacologic options for symptomatic management: duloxetine, pregabalin, and gabapentin 1, 2, 3, 4
  • Alternative options if first-line agents fail: tricyclic antidepressants (amitriptyline), topical capsaicin (8% patch or 0.075% cream) 3
  • Physical activity is recommended for both chemotherapy-induced and diabetic neuropathy 3, 4
  • Acupuncture may be offered for musculoskeletal-related neuropathic symptoms 4

Common Pitfalls and Monitoring

  • Do NOT use acetyl-L-carnitine for prevention of chemotherapy-induced peripheral neuropathy (harms outweigh benefits) 5
  • Avoid opioids (tapentadol, tramadol) for chronic neuropathic pain due to addiction risk 3
  • Monitor metformin users closely for B12 deficiency, as long-term use causes neuropathy in a stocking-glove distribution 1
  • Annual foot examinations with 10-g monofilament testing are mandatory once loss of protective sensation is documented to prevent ulceration 2, 3
  • Start medications at lower doses in older patients and titrate slowly to minimize adverse events 3

REFERENCES

1

Differential Diagnoses for Generalized Numbness and Tingling [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Evaluation and Management of Bilateral Peripheral Neuropathy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Diabetic Peripheral Neuropathy Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025